An Israeli researcher has developed and successfully tested a new device to combat glioblastoma mulitforme (GBM), the most common and aggressive type of brain cancer.
Professor Emeritus Yoram Palti Haifa’s Technion Institute told the website Israel21c that in tests on 10 cancer patients over the past year, his device has more than doubled the median overall survival rate of GBM patients.
The overwhelming success of tests has prompted 12 cancer centers in the US and anther eight in Europe to initiate large-scale studies of the method.
Palti's device consists of small nodes that are attached to the scalp and use electrical fields to kill the cancer cells by interfering with the division of the cells, thereby arresting the growth of the tumor.
The nodes are powered by a small battery pack, allowing patients to undergo constant treatment while going about their daily lives. Unlike chemotherapy, there are no side-effects.